In addition to data from the HIMSS Analytics® Database and unique insight from healthcare IT executives across the country, this year's Study includes year-over-year comparisons with information from the 2014 U.S. Telemedicine Study. Highlights include:
- An uptick in adoption and increase in familiarity with telemedicine products and services (YOY)
- 70% of respondents reported two-way video/webcam usage, making it the most utilized telemedicine product/solution
- Detailed insight into respondents’ telemedicine/telehealth services five year outlook
MORE RESEARCH REPORTS
While Picture Archive Communications System or PACS adoption across healthcare is high, potential growth opportunities abound.
This year’s study is a follow-up to the HIMSS Analytics 2013 C&BI study. While both studies reflect positively on C&BI’s market potential, there were notable differences, especially around the proposed application of C&BI solutions. In 2013, organizations were primarily interested in using C&BI to support their accountable care efforts, whereas in 2015, primary C&BI focus had shifted to population health.
This latest installment in the Revenue Cycle series is an expanded follow-up to the 2013 Inpatient Revenue Cycle study. Key findings include:
- An uptick in the usage of automated revenue cycle patient access solutions between 2013 and 2015,
- Over 70% of study respondents that use patient access solutions do so via hosted, web-based, Software as a Service (SaaS) deployment method for at least one function
- As patient portals are increasingly used to address patient access functionality, portal growth increased 15 percentage points from 2014 to 2015
HIMSS Analytics® has released its 2016 Clinical & Business Intelligence (C&BI) Essentials Brief, a study snapshot on the U.S. hospital analytics market.
As the emphasis of healthcare changes from volume to value-based care, the use of analytical solutions will be necessary to support clinical, financial and operational decision making. However, market adoption has been modest to date and plans to make future investments in clinical and business intelligence solutions are uncertain.
Purchase this study to: